Multiple frequency Bioimpedance Devicess

Multiple Frequency Bioimpedance Devices Market Outlook

The global bioimpedance devices market is poised for substantial growth, with a projected market size of approximately USD 1.5 billion in 2025, expected to reach around USD 2.8 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This growth can be attributed to increasing health awareness among individuals, rising incidences of obesity-related diseases, and the growing adoption of advanced diagnostic technologies. As healthcare systems continue to evolve, the demand for non-invasive and cost-effective methods of body composition analysis and disease diagnosis has surged, further driving the expansion of the bioimpedance devices segment. Additionally, the rising trend of fitness monitoring has led to a higher adoption rate of wearable bioimpedance devices, making them increasingly popular in consumer markets.

Growth Factor of the Market

Several factors are contributing to the growth of the bioimpedance devices market, including the surge in healthcare expenditure and the need for accurate and real-time health monitoring devices. As healthcare professionals and patients alike seek more efficient and non-invasive methods for assessing body composition and related health metrics, bioimpedance devices are becoming an increasingly preferred option. Moreover, technological advancements in multi-frequency bioimpedance technology are enhancing the accuracy and reliability of these devices, which is crucial for clinical applications. The increasing prevalence of chronic diseases, such as obesity and diabetes, necessitates regular monitoring of body composition, which further integrates bioimpedance devices into routine healthcare. The growing trend of telemedicine and remote patient monitoring has also positively influenced the market, as these devices enable healthcare providers to gather valuable data without the need for in-person visits. Lastly, the rise of the health and wellness sector, particularly among younger consumers, is driving innovation and demand for portable and user-friendly bioimpedance devices.

Key Highlights of the Market

• The global market for bioimpedance devices is expected to grow significantly over the next decade, with robust demand across various applications.
• Technological advancements, especially in multi-frequency and wireless bioimpedance devices, are paving the way for more accurate and convenient solutions.
• Rising prevalence of obesity and related comorbidities is driving the demand for body composition analysis tools.
• Growing adoption of wearable health devices is significantly contributing to market growth.
• Increased investments in healthcare infrastructure across developing regions are expected to bolster market expansion.

By Product Type

Single Frequency Bioimpedance Devices:

Single frequency bioimpedance devices are widely used in clinical settings for basic body composition assessments. These devices operate by applying a low electrical current through the body and measuring the impedance or resistance to that current. The simplicity and cost-effectiveness of single frequency devices make them accessible for various healthcare applications, particularly in outpatient settings. However, while they provide valuable information on body fat and lean mass, their reliance on a single frequency can limit the precision of the measurements. This has led to a growing preference for multi-frequency devices, which can offer more comprehensive insights into body composition.

Multiple Frequency Bioimpedance Devices:

Multiple frequency bioimpedance devices offer enhanced accuracy and detail by employing different frequencies to measure body composition. These devices are particularly beneficial in research and clinical environments, providing crucial information about the distribution of intracellular and extracellular fluids, body cell mass, and overall hydration status. The versatility of multiple frequency devices allows healthcare professionals to make informed decisions regarding patient care and treatment plans. Given their superior performance in accurately assessing body composition, these devices are gaining popularity among health professionals and patients alike, thereby driving market growth.

Wireless Bioimpedance Devices:

Wireless bioimpedance devices are revolutionizing the way individuals monitor their health. By incorporating wireless technology, these devices enable users to track their body composition and health metrics conveniently through mobile applications. The ability to gather data without direct cable connections enhances user experience and promotes regular monitoring. These devices are particularly appealing to fitness enthusiasts and people managing chronic conditions, as they offer portability and ease of use. The trend towards remote health monitoring is expected to further accelerate the adoption of wireless bioimpedance devices, contributing to their growth in the overall market.

Wearable Bioimpedance Devices:

Wearable bioimpedance devices represent the intersection of health technology and consumer electronics, allowing users to monitor their body composition in real-time. These devices, which can take the form of smartwatches or fitness trackers, are designed to provide insights into body fat percentage, muscle mass, and hydration levels through user-friendly interfaces. The growing consumer trend towards health and fitness, coupled with advancements in wearable technology, has made these devices increasingly popular. The convenience they offer—allowing users to track their health metrics continuously—positions them as a valuable tool in preventive healthcare and fitness monitoring.

Standalone Bioimpedance Devices:

Standalone bioimpedance devices are typically used in clinical and research settings for dedicated body composition analysis. These devices function independently from other systems, providing high-quality measurements with minimal user intervention. Their design is optimized for accurate readings in controlled environments, making them essential tools in medical diagnostics and health assessments. With the increasing need for precise body composition analysis for obesity management and metabolic health assessments, standalone devices continue to play a significant role in the bioimpedance market, especially in hospitals and specialized clinics.

By Application

Body Composition Analysis:

Body composition analysis is one of the primary applications for bioimpedance devices, helping healthcare professionals evaluate the distribution of fat and lean tissues in the body. This analysis is crucial for diagnosing obesity and related health conditions, providing a clearer understanding of a patient’s overall health. As obesity rates continue to rise globally, the demand for effective body composition analysis tools is burgeoning. Bioimpedance devices facilitate quick and non-invasive assessments, making them a valuable resource in both clinical and fitness settings for tracking weight management and health progress.

Disease Diagnosis:

Bioimpedance devices play an increasingly critical role in disease diagnosis, particularly for conditions related to fluid balance and nutrition. These devices can provide essential insights into a patient's hydration status, extracellular fluid levels, and body cell mass, which are vital metrics for managing diseases like heart failure, kidney disease, and diabetes. The ability to monitor these parameters non-invasively allows for timely interventions and adjustments in treatment plans, enhancing patient outcomes. As healthcare moves towards more personalized medicine, the role of bioimpedance devices in disease diagnosis is expected to expand significantly.

Fitness Monitoring:

Fitness monitoring has emerged as a significant application for bioimpedance devices, particularly with the rise of health-conscious consumers seeking to maintain or improve their physical condition. These devices enable individuals to track their body composition metrics, such as fat mass and muscle mass, providing insights to help them achieve their fitness goals. With the proliferation of fitness apps and wearable technology, bioimpedance devices are becoming integral tools for personal trainers and fitness enthusiasts alike. The convenience of real-time data access encourages regular use and adherence to fitness regimens, thus driving market growth in this segment.

Others:

In addition to the aforementioned applications, bioimpedance devices are utilized in various other fields, including research, clinical trials, and nutritional assessments. These devices offer a non-invasive method for gathering data related to body composition, which can be valuable in scientific studies exploring metabolic functions, nutritional interventions, and health outcomes. As researchers increasingly recognize the importance of body composition in understanding health and disease, the application of bioimpedance devices in research settings is anticipated to grow, contributing to a diversified market landscape.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics remain a dominant distribution channel for bioimpedance devices, primarily due to their essential role in patient care and diagnostics. These settings utilize bioimpedance devices for various applications, including body composition analysis and disease management. The demand for accurate and real-time health monitoring tools has led to significant investments in advanced bioimpedance technology within healthcare facilities. Additionally, the growing emphasis on preventive healthcare and chronic disease management is further driving the adoption of these devices in hospitals and clinics, ensuring their continued dominance in the distribution landscape.

Specialty Centers:

Specialty centers, such as obesity clinics and rehabilitation facilities, are increasingly incorporating bioimpedance devices into their assessment and treatment protocols. These centers focus on specific health conditions, where accurate body composition measurements are critical. The tailored approach provided by bioimpedance devices helps specialists develop personalized treatment plans based on individual patient profiles. As the importance of specialized healthcare continues to rise, the presence of bioimpedance devices in these centers is anticipated to grow, providing patients with advanced healthcare solutions.

Online Stores:

The rise of e-commerce has transformed the way consumers access bioimpedance devices, with online stores becoming a significant distribution channel. Consumers are increasingly turning to online platforms for purchasing fitness and health monitoring devices due to the convenience and variety of options available. This trend is further supported by the increasing health awareness and the demand for personal health management tools among the general public. Online shopping allows consumers to compare products easily, read reviews, and often access better pricing, which is expected to drive growth in the online distribution segment of the bioimpedance market.

Others:

Other distribution channels for bioimpedance devices include pharmacies, health and wellness stores, and direct sales through manufacturers. Pharmacies are becoming more involved in the distribution of health monitoring devices, offering consumers easy access to bioimpedance technology for personal health management. Health and wellness stores also cater to a growing market segment that seeks to enhance their fitness and health through advanced devices. Additionally, manufacturers often engage in direct sales to hospitals and clinics, ensuring that their products are utilized effectively within healthcare settings. As the market evolves, the presence of these diverse distribution channels is expected to expand, accommodating the varying needs of consumers.

By Technology

Direct Segmental Multi-Frequency Bioelectrical Impedance Analysis:

Direct segmental multi-frequency bioelectrical impedance analysis is a cutting-edge technology that provides detailed insights into body composition across various segments of the body. This technique uses multiple frequencies to assess the different types of tissues, such as fat, lean muscle, and water, delivering precise data that is crucial for healthcare professionals. The increasing demand for high-resolution body composition analysis in clinical and fitness settings is driving the adoption of devices utilizing this technology. As a result, the market for direct segmental multi-frequency bioelectrical impedance analysis is expected to grow as healthcare providers seek more advanced solutions for patient assessments.

Bioimpedance Spectroscopy:

Bioimpedance spectroscopy is another sophisticated technology that measures the frequency-dependent changes in impedance to provide comprehensive data on body composition. This method allows for the differentiation between various body compartments, such as fat mass, fat-free mass, and total body water. The precision and accuracy offered by bioimpedance spectroscopy make it particularly useful in clinical research, where detailed body composition assessments are essential. As researchers and clinicians increasingly recognize the value of this technology, its market share is expected to grow, particularly in specialized healthcare environments.

Tetrapolar Bioimpedance Analysis:

Tetrapolar bioimpedance analysis is a popular method employed in many clinical and research applications due to its ability to minimize measurement errors. This technology uses four electrodes to measure impedance, allowing for a more accurate assessment of body composition. The reduced sensitivity to external factors, such as skin impedance and electrode placement, enhances the reliability of the measurements. As healthcare professionals continue to prioritize accurate body composition analysis, the demand for tetrapolar bioimpedance devices is likely to rise, solidifying their position in the market.

Octapolar Bioimpedance Analysis:

Octapolar bioimpedance analysis is an advanced technique that utilizes eight electrodes to provide even more detailed measurements of body composition and fluid distribution. This technology enhances the accuracy and precision of impedance measurements, making it particularly valuable for clinical assessments. The ability to analyze multiple segments of the body simultaneously allows healthcare providers to make more informed decisions regarding patient care. As the importance of precise body composition analysis continues to grow, octapolar bioimpedance analysis is expected to gain traction among healthcare professionals and researchers alike.

Others:

Other technologies in the bioimpedance market include advancements like the application of machine learning algorithms to enhance the analysis of bioimpedance data. These emerging technologies seek to streamline the interpretation of complex data sets and improve the overall user experience. Furthermore, innovations such as integrating smartphone applications with bioimpedance devices are paving the way for more interactive health monitoring solutions. As technology continues to evolve, the market for bioimpedance devices will likely see an influx of new and improved methods, catering to the diverse needs of healthcare providers and consumers.

By Region

The North American bioimpedance devices market is the largest globally, accounting for approximately 38% of the total market share in 2025. This dominance can be attributed to advanced healthcare infrastructure, high healthcare expenditure, and a growing focus on preventive health measures among the population. The presence of key players in the region and ongoing innovations in bioimpedance technology further support the market's robust growth. With an anticipated CAGR of 7.2% during the forecast period, North America is expected to maintain its leading position, propelled by increasing health awareness and the rising demand for fitness monitoring solutions.

Europe holds the second largest market share, making up around 30% of the global bioimpedance devices market in 2025. The region benefits from a strong emphasis on research and development in healthcare technologies and increasing investments in healthcare infrastructure. Additionally, the aging population in European countries is driving the demand for effective body composition analysis and disease management tools. The overall growth in Europe is projected to reach a CAGR of 5.8% from 2025 to 2035, as healthcare providers seek innovative solutions to address the rising prevalence of lifestyle-related diseases.

Opportunities

The bioimpedance devices market is poised to harness several promising opportunities that can facilitate its growth in the coming years. One of the most significant opportunities lies in the increasing adoption of telehealth and remote monitoring solutions. As healthcare providers continue to seek ways to improve patient engagement and adherence to treatment plans, bioimpedance devices can serve as a valuable tool for remote assessments. This shift towards digital healthcare solutions aligns perfectly with the capabilities of bioimpedance technology, allowing patients to monitor their body composition and health metrics from the comfort of their homes. Consequently, the integration of bioimpedance devices into telehealth platforms is expected to present a lucrative opportunity for manufacturers and healthcare providers alike.

Additionally, the rising trend of personalized healthcare offers substantial growth potential for bioimpedance devices. Consumers are increasingly interested in tailored health solutions that cater to their unique needs and goals. Bioimpedance devices can provide valuable data that assist healthcare professionals in developing personalized nutrition and exercise plans. Furthermore, the health and wellness industry's expansion, particularly among younger demographics, underscores the demand for innovative and accessible health monitoring tools. As manufacturers enhance bioimpedance technology to meet consumer expectations for usability and connectivity, the market is likely to experience increased demand, leading to further opportunities for growth.

Threats

Despite the promising growth trajectory of the bioimpedance devices market, several threats could hinder its progress. One notable concern is the presence of alternative technologies and methods for body composition analysis, such as dual-energy X-ray absorptiometry (DEXA) and magnetic resonance imaging (MRI). These methods are often perceived as more accurate, and their established presence in the market can pose a competitive threat to bioimpedance devices. Healthcare professionals may prefer traditional imaging techniques, particularly for clinical applications, potentially limiting the adoption of bioimpedance technology. To mitigate this threat, manufacturers must focus on highlighting the advantages of bioimpedance devices, such as their non-invasive nature and ease of use, to promote their acceptance among healthcare providers.

Another significant threat is the potential for regulatory challenges and compliance issues that manufacturers may face when introducing new bioimpedance devices to the market. Stricter regulations and standards can complicate the approval process, leading to delays in product launches and increased costs for manufacturers. As technology evolves, regulatory bodies may impose additional requirements to ensure patient safety and device efficacy, which could further strain resources. Companies in the bioimpedance devices market must navigate these challenges effectively to sustain their business operations and maintain their competitive edge.

Competitor Outlook

• ImpediMed Limited
• InBody Co., Ltd.
• Tanita Corporation
• Omron Healthcare, Inc.
• Bodystat Limited
• seca GmbH & Co. KG
• Fresenius Medical Care AG & Co. KGaA
• BEESY, LLC
• BodyMetrix
• Nutritional Technologies, Inc.
• Fresenius Kabi
• Huntleigh Healthcare
• Medtronic plc
• BodyTrace, Inc.
• Bioelectronic Corporation

The competitive landscape of the bioimpedance devices market is characterized by a diverse array of players, ranging from established healthcare companies to innovative startups. Market leaders such as ImpediMed Limited and InBody Co., Ltd. have set benchmarks for product quality and technological advancements, constantly investing in research and development to enhance their offerings. The presence of multiple competitors in this space fosters a dynamic environment where innovation thrives, ultimately benefiting consumers. Furthermore, strategic partnerships and collaborations among players are becoming increasingly common as they seek to expand their market presence and leverage complementary expertise in technology and healthcare.

Major companies are focusing on product differentiation and technological advancements to maintain their competitive edge in the bioimpedance devices market. For instance, Tanita Corporation has been a pioneer in developing user-friendly bioimpedance scales for both clinical and personal use, combining advanced technology with aesthetic design. Similarly, Omron Healthcare, Inc. has leveraged its strong brand reputation to introduce innovative health monitoring devices that integrate bioimpedance technology for comprehensive health assessments. As companies continue to innovate and address the evolving needs of healthcare providers and consumers, they position themselves favorably in the competitive landscape.

Furthermore, market players are also exploring global expansion opportunities to capture emerging markets, particularly in regions like Asia Pacific and Latin America. With rising healthcare expenditures and increasing awareness regarding preventive healthcare in these regions, companies see significant potential for growth. For example, Fresenius Medical Care is focusing on expanding its product offerings to include bioimpedance devices tailored for specific clinical applications, creating targeted solutions for healthcare providers. As the bioimpedance market continues to evolve, the competitive landscape will remain dynamic, with both established and emerging companies vying for market share.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BEESY, LLC
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 BodyMetrix
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Fresenius Kabi
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 BodyTrace, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Bodystat Limited
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 InBody Co., Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ImpediMed Limited
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Tanita Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 seca GmbH & Co. KG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Huntleigh Healthcare
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Omron Healthcare, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bioelectronic Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Nutritional Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fresenius Medical Care AG & Co. KGaA
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Multiple frequency Bioimpedance Devicess Market, By Technology
    • 6.1.1 Direct Segmental Multi-Frequency Bioelectrical Impedance Analysis
    • 6.1.2 Bioimpedance Spectroscopy
    • 6.1.3 Tetrapolar Bioimpedance Analysis
    • 6.1.4 Octapolar Bioimpedance Analysis
    • 6.1.5 Others
  • 6.2 Multiple frequency Bioimpedance Devicess Market, By Application
    • 6.2.1 Body Composition Analysis
    • 6.2.2 Disease Diagnosis
    • 6.2.3 Fitness Monitoring
    • 6.2.4 Others
  • 6.3 Multiple frequency Bioimpedance Devicess Market, By Product Type
    • 6.3.1 Single Frequency Bioimpedance Devices
    • 6.3.2 Multiple Frequency Bioimpedance Devices
    • 6.3.3 Wireless Bioimpedance Devices
    • 6.3.4 Wearable Bioimpedance Devices
    • 6.3.5 Standalone Bioimpedance Devices
  • 6.4 Multiple frequency Bioimpedance Devicess Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Specialty Centers
    • 6.4.3 Online Stores
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Multiple frequency Bioimpedance Devicess Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Multiple frequency Bioimpedance Devicess market is categorized based on

By Product Type

• Single Frequency Bioimpedance Devices
• Multiple Frequency Bioimpedance Devices
• Wireless Bioimpedance Devices
• Wearable Bioimpedance Devices
• Standalone Bioimpedance Devices

By Application

• Body Composition Analysis
• Disease Diagnosis
• Fitness Monitoring
• Others

By Distribution Channel

• Hospitals & Clinics
• Specialty Centers
• Online Stores
• Others

By Technology

• Direct Segmental Multi-Frequency Bioelectrical Impedance Analysis
• Bioimpedance Spectroscopy
• Tetrapolar Bioimpedance Analysis
• Octapolar Bioimpedance Analysis
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• ImpediMed Limited
• InBody Co., Ltd.
• Tanita Corporation
• Omron Healthcare, Inc.
• Bodystat Limited
• seca GmbH & Co. KG
• Fresenius Medical Care AG & Co. KGaA
• BEESY, LLC
• BodyMetrix
• Nutritional Technologies, Inc.
• Fresenius Kabi
• Huntleigh Healthcare
• Medtronic plc
• BodyTrace, Inc.
• Bioelectronic Corporation